S&P Little Changed Amid Trump Moves on Trade
The S&P 500 ended Tuesday’s session near the flatline after President Donald Trump offered no exceptions to his Aug. 1 tariff start date.The Dow Jones Industrials slumped 165.6 points to 44,240.76.The much-broader index fell short of breakeven by 4.46 points to 6,225.52.The NASDAQ Composite edged up 5.95 points to 20,418.46.Traders had trouble keeping up with the conflicting signals from Trump on trade. Trump on Monday pushed the tariff deadline to Aug. 1 from July 9. Later that day, he said that the new deadline was “not 100% firm.”However, on Tuesday, the president posted on Truth Social that there would be no change or extensions granted to the Aug. 1 date. The same day, Trump also announced a steep 50% tariff on copper imports.Overall, at least 14 countries are set to face new duties including South Africa and Kazakhstan.However, some traders no longer forecast the latest U.S. tariffs to be as strict as initially feared, with many expecting that the worst from the trade war has now passed.On the upside, Nvidia nudged higher, closing in on a $4-trillion market cap. But banks helped weigh down the market, after HSBC adopted a “more cautious stance” on larger banks. Shares of JPMorgan and Bank of America shed 3%, while Goldman Sachs slipped 2%.Prices for the 10-year treasury were lower, raising yields to 4.41% from Monday’s 4.39%. Treasury prices and yields move in opposite directions. Oil prices recovered 46 cents to $68.39 U.S. a barrel. Gold prices dropped $29.30 to $3,313.50 U.S. an ounce.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


